Erlocip 150mg (Erlotinib)
Erlocip 150mg contains Erlotinib, a targeted therapy used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase, a protein that plays a crucial role in cancer cell growth. By blocking EGFR signaling, Erlocip helps slow the progression of cancer and can improve outcomes in patients with specific mutations in the EGFR gene.
PACK SIZE | PRICE | QTY | ADD TO CART | |
---|---|---|---|---|
30 Tablet/s | ($6.63/Tablet/s) |
|||
60 Tablet/s | ($6.33/Tablet/s) |
|||
90 Tablet/s | ($6.1/Tablet/s) |
|||
SKU : | Status : In Stock | Coupon Code : FREE10 |
Created at : 30-12-2024 Author : Aston Carter |
Updated at : 30-12-2024 Medically Reviewd By : Dr. Peter Hales |
Buy Erlocip 150mg Online in the USA
Erlocip 150mg (Erlotinib) is available for secure and easy online purchase in the USA. This medication, primarily used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer, is now more accessible than ever. With fast and reliable shipping, you can get the medication you need delivered right to your door. Our secure payment options and efficient customer support ensure that your order is processed smoothly and delivered on time. Start your treatment journey today with Erlocip 150mg, available at competitive prices.
How to Use
How to Use Erlocip 150mg (Erlotinib)
Erlocip 150mg (Erlotinib) comes in tablet form and should be taken orally, as directed by your healthcare provider. Typically, the dosage is one 150mg tablet once a day, preferably on an empty stomach (at least one hour before or two hours after eating). Gulp down the tablet without smashing or biting it. Taking Erlocip simultaneously every day for the best results is significant. In the event that you miss a portion, accept it when you recollect, except if it's nearly time for your next portion. Try not to twofold the portion to compensate for a missed one. Continuously adhere to the dosing directions given by your primary care physician.
Active Ingredients
Active Ingredient: Erlotinib
Erlocip contains Erlotinib, an oral targeted therapy drug that works by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase. This chemical is associated with the development and spread of disease cells. By blocking EGFR, Erlotinib helps prevent the activation of signals that would otherwise encourage the growth of cancerous cells. It is primarily used in the treatment of advanced non-small cell lung cancer (NSCLC) and in combination with other medications for pancreatic cancer. Erlotinib is most effective in patients whose tumors have certain genetic mutations that make them sensitive to this treatment.
Side Effects
Possible Side Effects of Erlocip 150mg (Erlotinib)
Like all medications, Erlocip 150mg may cause side effects. Common side effects include:
- Diarrhea
- Skin rash or dryness
- Fatigue
- Loss of appetite
- Nausea
Serious side effects, though rare, may include:
- Interstitial lung disease (difficulty breathing, coughing, or fever)
- Liver problems (e.g., jaundice, dark urine, severe abdominal pain)
- Eye problems (such as vision changes or eye irritation)
- Severe skin reactions (blistering or peeling of the skin)
If you experience any of these more severe symptoms or have concerns about side effects, contact your healthcare provider immediately.
Benefits
Benefits of Erlocip 150mg (Erlotinib)
Erlocip offers several important benefits for patients with advanced cancers:
- Effective in non-small cell lung cancer (NSCLC): Erlotinib has been shown to improve survival in patients with EGFR mutation-positive NSCLC, particularly for those who have progressed after chemotherapy.
- Targeted therapy: By specifically targeting EGFR, Erlotinib helps to block the signals that drive cancer cell growth, leading to tumor shrinkage and slower cancer progression.
- Improved survival outcomes: In patients with advanced pancreatic cancer, when used alongside other treatments, Erlotinib can help improve overall survival rates.
- Well-tolerated: Although side effects may occur, Erlotinib is generally well-tolerated by patients who meet the criteria for treatment, improving both quality of life and treatment outcomes.
0 Reviews For Erlocip 150mg (Erlotinib)
Active Ingredient | Erlotinib Tablets Ip 150 Mg |
---|---|
Manufacturer | Cipla Limited |
Delivery Time | 7 To 14 Days |
SKU: |
What is Erlocip 150mg used for?
Erlocip 150mg is used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer, especially in cases where the cancer has specific genetic mutations (e.g., EGFR mutations).
How should I take Erlocip 150mg?
Erlocip 150mg should be taken orally, usually once a day, with or without food. Swallow the tablet whole and avoid crushing or breaking it.
What are the common side effects of Erlocip?
Common side effects include skin rashes, diarrhea, fatigue, loss of appetite, and nausea. It may also cause dry skin or eye irritation.
Can Erlocip 150mg be taken with other medications?
Erlocip can interact with other medications, particularly those that affect liver enzymes. Always inform your doctor of all the medications or supplements you are taking.
Can Erlocip 150mg be used in combination with chemotherapy?
Erlocip may be used with chemotherapy or other cancer treatments, depending on your condition. Always follow your doctor's guidance on combination therapy.
Similar Products
Category and products of Anti Cancer